
Soft start masks structural headwinds—guidance credibility strained
enzyme biotech · soft growth · margin compression
BSE: 540025
P/L Snapshot
Q1 FY27 · standalone
Shareholding
Pattern breakdown
P/L Trends
(in crores)

enzyme biotech · soft growth · margin compression

sales reversal · margin compression · US business stalled

enzymes · margin compression · consolidated results
Corporate Events
Board Meeting
The Board of Directors will consider and approve the Un-audi…
BSE Filing ↗Board Meeting
The 37th Annual General Meeting ("AGM") of the Company will …
BSE Filing ↗Board Meeting
The Board meeting discussed and approved the re-appointment …
BSE Filing ↗Board Meeting
consider and approve Un-audited Financial Results (Standalon…
BSE Filing ↗Board Meeting
Consider and approve Un-audited Financial Results (Standalon…
BSE Filing ↗Board Meeting
Consider and approve annual Financial Statements, recommend …
BSE Filing ↗Board Meeting
Consider and approve Un-audited Financial Results (Standalon…
BSE Filing ↗Board Meeting
Consider and approve Un-audited Financial Results (Standalon…
BSE Filing ↗Board Meeting
Consider and approve Un-audited Financial Results (Standalon…
BSE Filing ↗